IMG Wealth Management Inc. Buys New Position in HCA Healthcare, Inc. (NYSE:HCA)

IMG Wealth Management Inc. bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 454 shares of the company’s stock, valued at approximately $136,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Gallacher Capital Management LLC raised its stake in HCA Healthcare by 4.9% during the 4th quarter. Gallacher Capital Management LLC now owns 1,679 shares of the company’s stock worth $504,000 after buying an additional 79 shares during the period. Corient Private Wealth LLC raised its stake in HCA Healthcare by 1.0% during the 4th quarter. Corient Private Wealth LLC now owns 39,067 shares of the company’s stock worth $11,724,000 after buying an additional 381 shares during the period. Envestnet Portfolio Solutions Inc. raised its stake in shares of HCA Healthcare by 14.7% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,623 shares of the company’s stock worth $4,689,000 after purchasing an additional 2,002 shares during the last quarter. Tidemark LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth approximately $36,000. Finally, First Eagle Investment Management LLC raised its stake in shares of HCA Healthcare by 0.5% in the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after purchasing an additional 23,177 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $319.82 on Monday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The business has a fifty day moving average price of $319.00 and a 200-day moving average price of $344.95. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm has a market capitalization of $78.74 billion, a P/E ratio of 14.56, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the company earned $5.90 earnings per share. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.90%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on HCA. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Royal Bank of Canada lowered their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. KeyCorp decreased their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, Barclays decreased their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.